SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-057273
Filing Date
2023-12-12
Accepted
2023-12-12 07:42:04
Documents
4
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A edge20015072x3_def14a.htm DEF 14A 424849
2 edge20015072x3_pc01.jpg GRAPHIC 532962
3 edge20015072x3_pc02.jpg GRAPHIC 426010
4 logo_evelobiosciences.jpg GRAPHIC 28227
  Complete submission text file 0001140361-23-057273.txt   1784654
Mailing Address 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38473 | Film No.: 231479968
SIC: 2834 Pharmaceutical Preparations